Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Melanoma Adjuvant/Neoadjuvant

Georgina Long

MBBS, PhD

🏢Melanoma Institute Australia / University of Sydney🌐Australia

Co-Medical Director, Melanoma Institute Australia

98
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Georgina Long is a world leader in melanoma who has pioneered neoadjuvant immunotherapy approaches demonstrating remarkable pathological complete response rates. Her OPACIN-neo and subsequent trials have established the neoadjuvant paradigm as a transformative treatment strategy. She leads the Melanoma Institute Australia and drives global melanoma research collaborations.

Share:

🧪Research Fields 研究领域

Melanoma
Neoadjuvant immunotherapy
Adjuvant therapy
Combination immunotherapy
Clinical trial design

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Georgina Long 的研究动态

Follow Georgina Long's research updates

留下邮箱,当我们发布与 Georgina Long(Melanoma Institute Australia / University of Sydney)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment